Liquidia Corporation (LQDA)
LQDA price $38.88 +2.53 +6.97%
- Ticker
- LQDA
- Price
- $38.88
- Change
- +2.53 +6.97%
- Market cap
- $3.48B
- P/E
- 45.28
- Forward P/E
- 12.67
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its…